By Alex Chou, Samantha Lee, Charlotte Wu, Kevin Chuang, and Sophia Fang (National Taiwan University) Photo: Markus Frieauff (Unsplash) Overview of the deal Acquirer: Abbott Laboratories (NYSE: ABT) Target: Exact Sciences Corporation (NASDAQ: EXAS) Implied Equity Value: USD ~$21 billion Total Transaction Size: USD ~$23 billion Announcement date: November 20, 2025 Closing date: March 23, 2026 Target advisor: Centerview Partners LLC, XMS Capital Partners LLC (Financial); Skadden